Natural Nutraceutical Patent Strategy Case Studies
Business Insights
September 15, 2011 147 Pages - SKU: RET6647592
|
|
The adoption of more stringent regulation is forcing functional food manufacturers to invest greater resources in research and development in order to fully substantiate product health claims. This investment, added to the level of industry competition, ensures that companies must secure adequate patent protection. This report analyzes the strategies of eight innovative nutraceutical developers.
Compare and contrast the patent strategies being used by some of the most innovative companies in the nutraceutical industry.
Identify weaknesses in patent strategies and possible areas of opportunity.
Identify products and companies which offer good investment opportunities.
Evaluate new nutraceuticals under development and identify the disease areas and health claims being pursued.
Identify key active principles being targeted and their health benefits for certain disease types.
The range of companies involved in developing nutraceuticals serves to highlight the different patenting strategies and business models being used. Some manufacturers, such as Evgen, in-license an entire IP portfolio, while companies like Provexis use a mixture of licensed-in IP and in-house development.
Avesthagen's IP business model has evolved, having originally acquired a company that was an early adopter of Ayurvedic medicine patenting. The company has since developed its own in-house screening technologies and patenting, and more recently applied cutting-edge gene transfer techniques to improve the yield of active principles in plant species.
With many modern natural nutraceuticals based upon traditional ingredients that have already been the subject of considerable research and patenting activity, licensing intellectual property will be a key strategic element for any manufacturer wishing to develop successful products.
What are the patent strategies of the successful innovative nutraceutical companies?
What effect has the recent clamp down on unsubstantiated health claims had on recent patenting activity in nutraceuticals?
How do companies use licensing to complement their intellectual property portfolios?
Which companies are patenting natural nutraceuticals and natural pharmaceuticals in the same patent applications?
Which countries have strong companies involved in developing new nutraceuticals and what are the factors that are encouraging this success?
|
- Disclaimer
- EXECUTIVE SUMMARY
- Patenting strategies
- Innovative company patent strategies
- Conclusions
- Introduction
- The patents landscape
- What is this report about?
- Patent strategies
- Introduction
- What is a patent?
- Requirement for a therapeutic patent
- Legal patent frameworks
- United States
- European
- Patent Cooperation Treaty
- Patenting costs
- EPO patenting fees
- WIPO patenting fees
- USPTO fees
- Types of patent claims for natural nutraceuticals versus NCEs
- Health claims of natural nutraceuticals often arise from folklore
- Process patenting strategies for natural nutraceuticals versus drugs
- Formulation patenting strategies for nutraceutical versus drugs
- Patent term extensions
- Differences in NCE and natural nutraceutical patenting
- New chemical entities
- Natural nutraceuticals
- Future patenting strategies
- Evgen Limited
- History, background and management
- Evgen strategy overview
- Product portfolio
- Evgen’s IP licensing-in strategy
- PharmAgra
- Kraft Foods
- Harnessing gene technology for improved production
- Wider potential for sulforaphane
- Other companies patenting in this area
- John Hopkins University
- Wassen Int Ltd
- Amway Corp
- The American Health Foundation
- Bejo Zaden BV
- Inventor - Gu Hong Park
- US Department of Agriculture
- Seoul National University’s SNU R&DB Foundation
- Provexis Natural Products Limited and Plant Bioscience Limited
- Case study - Provexis
- History, background and management
- Provexis strategy overview
- Product portfolio
- Fruitflow
- NSP*3G plantain extract
- Isothiocyanates
- DSM’s patent portfolio for healthy blood glucose levels
- Case study - Exichol
- History, background and management
- Exichol strategy overview
- Exichol’s nutrigenomics patenting strategy
- Other inventors patenting in the nutrigenomics area
- Case study - Avesthagen
- History, background and management
- Avesthagen’s bioNutrition Group
- Avesthagen’s strategy overview
- Technology and assets
- Avesthagen’s natural nutraceutical patenting strategy
- Mangosteen - Garcinia mangostana
- Lagerstroemia speciosa
- Goji - Lycium barbarum
- Avesthagen’s “phytochemical” PCT applications
- Salacia extract
- Salacia, Cinnamomum and Eugenia extracts
- Trigonella foenum-graecum
- Punica granatum
- Gene transfer technology for improved active principle production
- Vittal Mallya Scientific Research Foundation (VMSRF)
- Case study - Naturalendo Tech
- History, background, management
- Naturalendo strategy overview
- Research and development
- Naturalendo Tech patenting portfolio
- Phytoestrogens - menopause
- Insomnia
- Diabetes
- Alopecia
- Case study - Laila Nutraceuticals
- History, background and management
- Laila Nutraceuticals highlights
- Laila Nutraceuticals patent application portfolio
- Boswellia serrata
- Curcuma longa
- Garcinia mangostana
- Annona squamosal
- Ficus hispida
- Holoptelea integrifolia
- Aphanamixis polystacha
- Lagerstromia sp.
- Case study - WellGen Inc.
- History, background and management
- WellGen highlights
- WellGen’s patenting strategy
- Black tea extracts
- Polymethylated flavones for weight management
- Other patenting in the area of black tea extract
- Case study - InnoVactiv Inc
- History, background and management
- InnoVactiv highlights:
- InSea2
- innoVactiv patenting strategy
- Other patenting in the area of red and brown algae
- Peptibal
- InnoVactiv’s cosmeceuticals
- Cosmeceutical patenting
- Patenting future outlook
- Summary
- Introduction
- Increased patent activity
- Protecting assets
- Licensing strategies
- Emerging markets
- New technologies
- Delivery systems
- Nutrigenomics
- Potential for associated pharmaceutical development
- Appendix
- Scope
- Methodology
- Secondary research
- Glossary/Abbreviations
- Bibliography/References
- Innovative companies case studies
Share this report
Other tasks Related Markets Regulation Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
